Funding

World Health Organization

January 2018 – May 2018 (completed)

₹ 650,000 (~US$10,000)

Project Brief

This study was conducted with funding support from the World Health Organization. In Indian healthcare facilities, patients suffering from diarrhea are frequently administered a combination of antibiotics, predominantly fluoroquinolones (FQ). Despite this common practice, there is limited research estimating the extent of FQ resistance among enteric bacteria in the gastrointestinal tract of diarrhea patients. To address this gap, the study aimed to evaluate the magnitude of FQ resistance in both commensal and diarrheagenic Escherichia coli isolated from clinical samples obtained through a facility-based surveillance of diarrhea patients in Kolkata.

Role & Responsbilities

As Co-Investigator, I led the development of the study protocol, including the formulation of a statistical plan of analysis. Additionally, I actively participated in the data analysis process and collaborated with the laboratory team in interpreting the findings. Subsequently, I contributed to the composition of a comprehensive report detailing the outcomes of the study, which was submitted to the funding agency, the World Health Organization.